Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

ClinicalTrials.gov ID: NCT00140036

Public ClinicalTrials.gov record NCT00140036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 5:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This protocol describes procedures for the collection of blood samples for the intent of determining genetic contribution to the safety and efficacy of CPT/FU/LV.

Study identification

NCT ID
NCT00140036
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
137 participants

Conditions and interventions

Interventions

Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2002 (Type not available)
Primary completion
Not listed
Completion
Aug 2005 (Type not available)
Last update posted
Mar 3, 2008

2002 – 2005

United States locations

U.S. sites
29
U.S. states
23
U.S. cities
29
Facility City State ZIP Site status
Pfizer Investigational Site Mobile Alabama 36608 —
Pfizer Investigational Site Tucson Arizona 85715 —
Pfizer Investigational Site Fresno California 93710 —
Pfizer Investigational Site Stamford Connecticut 06902 —
Pfizer Investigational Site Washington D.C. District of Columbia 20007 —
Pfizer Investigational Site Jacksonville Florida 32207 —
Pfizer Investigational Site New Port Richey Florida 34652 —
Pfizer Investigational Site Tamarac Florida 33321 —
Pfizer Investigational Site Rockford Illinois 61108-2472 —
Pfizer Investigational Site Terre Haute Indiana 47802 —
Pfizer Investigational Site New Orleans Louisiana 70115 —
Pfizer Investigational Site Annapolis Maryland 21401 —
Pfizer Investigational Site Pittsfield Massachusetts 01201 —
Pfizer Investigational Site Minneapolis Minnesota 55422 —
Pfizer Investigational Site Columbia Missouri 65212 —
Pfizer Investigational Site Billings Montana 59101 —
Pfizer Investigational Site Las Vegas Nevada 89106 —
Pfizer Investigational Site Hooksett New Hampshire 03106 —
Pfizer Investigational Site Lebanon New Hampshire 03756 —
Pfizer Investigational Site Rockville Centre New York 11570 —
Pfizer Investigational Site Greenville North Carolina 27834 —
Pfizer Investigational Site Hendersonville North Carolina 28738 —
Pfizer Investigational Site Hickory North Carolina 28602 —
Pfizer Investigational Site Winston-Salem North Carolina 27157 —
Pfizer Investigational Site Zanesville Ohio 43701 —
Pfizer Investigational Site Charleston South Carolina 29406 —
Pfizer Investigational Site Temple Texas 76508 —
Pfizer Investigational Site Newport News Virginia 23606 —
Pfizer Investigational Site Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00140036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2008 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00140036 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →